Merck's COVID pill a 'game-changer' - Scott Gottlieb_老虎社区_美港股上老虎

Merck's COVID pill a 'game-changer' - Scott Gottlieb

seekingalpha2021-10-01

Merck's(NYSE:MRK)COVID treatment pill resultsare "profoundly" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results. Gottlieb notes the trial was ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

448

Gee1
·2021-10-03
well done
回复
2
举报
Ermmmmmm
·2021-10-02
Okay
回复
点赞
举报
Jazling
·2021-10-02
Wow
回复
3
举报
收起
- Jazling:
  Ok
  2021-10-02
  回复
  举报
- Ljoney:
  Nice
  2021-10-02
  回复
  举报
Imgoh
·2021-10-02
No wonder vaccine stock drop so much
回复
2
举报
收起
- Baoxiaolong:
  you think this is over?
  2021-10-02
  回复
  举报
Nickystonks
·2021-10-02
Very interesting progress
回复
1
举报
Gackky
·2021-10-02
after vaccination , we will need to eat pill?! next will be nanabots perhaps
回复
2
举报
Tomxx
·2021-10-02
Like
回复
2
举报
收起
- Jweikit:
  Nice
  2021-10-02
  回复
  举报
HoSeyLiao48
·2021-10-02
Waiting for a liquid oral vaccine or a plaster type of vaccine.
回复
3
举报
收起
- cheekeong:
  ok
  2021-10-02
  回复
  举报
HoSeyLiao48
·2021-10-02
Truly a game changer.[强] [看涨] [看涨] [梭哈] [美金] [美金] [看涨] [财迷]
回复
3
举报
KYHBKO
·2021-10-02
this is a game changer without the restrictions of cold chain storage and transportation required, thus allowing this to reach more people especially in more remote areas. at the same time, some people would prefer to consume the pill than receiving injection. no surprise that the stock did well.
回复
11
举报
收起
- 714ec067:
  👍
  2021-10-02
  回复
  举报
- 滚股怪:
  Ya
  2021-10-02
  回复
  举报
- KLC:
  👍
  2021-10-02
  回复
  举报
查看更多 1 条评论
Andersonkana
·2021-10-02
Good news
回复
2
举报
Tongdadd
·2021-10-02
Hope they don't price this drug out of the reach of many poor countries
回复
2
举报
收起
- SmallYang:
  Agree. As it is, the vaccines are now almost out of reach to the poorer countries. :(
  2021-10-02
  回复
  举报
- Tongdadd:
  Crazy. US$700 per pill. One course is 5 days. Minimally US$3500 to pay for a course of medication. Profiteering by Big Pharma at its max. What happened to saving lives?
  2021-10-04
  回复
  举报
EHG
·2021-10-02
Like
回复
1
举报
UserTesting2
·2021-10-02
Ok
回复
3
举报
Benggggg
·2021-10-02
👍Ok
回复
3
举报
Kevin92
·2021-10-02
like and commet
回复
3
举报
JeffreyNeo
·2021-10-02
1
回复
6
举报
收起
- JeffreyNeo:
  1
  2021-10-02
  回复
  举报
- Kevin92:
  ‌like and commet
  2021-10-02
  回复
  举报
YauDK
·2021-10-02
Oh ye ye
回复
4
举报
收起
- YauDK:
  Oh ye ye
  2021-10-02
  回复
  举报
Sunny0809
·2021-10-02
Ok
回复
5
举报
DesmondChin
·2021-10-02
Nothing new, just another panaodol that protects against covid.. After 10years, no one would even remember what happen to this so called game changing events
回复
3
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1118501905?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-10-01 22:12","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1118501905","market":"us","top_or_hot":-1,"title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","media":"seekingalpha","content":"<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">网页链接</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","article_id":"1118501905","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","pubTimestamp":1633097579,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"默沙东的COVID药丸是“游戏规则的改变者”--斯科特·戈特利布","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{},"content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","kind":null,"is_publish_news":false,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":867102743,"gmtCreate":1633223158160,"gmtModify":1633223158417,"author":{"id":"3555136548043615","authorId":"3555136548043615","name":"Gee1","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"well done","listText":"well done","text":"well done","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/867102743","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":864736509,"gmtCreate":1633146779596,"gmtModify":1633146779979,"author":{"id":"4087557783698070","authorId":"4087557783698070","name":"Ermmmmmm","avatar":"https://static.tigerbbs.com/b89bbeb73fe9212f0b5efc7185ae8a51","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Okay&nbsp;","listText":"Okay&nbsp;","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864736509","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":864423171,"gmtCreate":1633140277980,"gmtModify":1633140278599,"author":{"id":"3566821013640470","authorId":"3566821013640470","name":"Jazling","avatar":"https://static.tigerbbs.com/85e0a83573d9307f57fca9b2baed72af","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/864423171","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6066544,"gmtCreate":1633140282719,"gmtModify":1634724251535,"authorId":3566821013640470,"author":{"id":3566821013640470,"authorId":3566821013640470,"name":"Jazling","avatar":"https://static.tigerbbs.com/85e0a83573d9307f57fca9b2baed72af","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":864423171,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":6066749,"gmtCreate":1633141059581,"gmtModify":1634724230395,"authorId":3581591015314710,"author":{"id":3581591015314710,"authorId":3581591015314710,"name":"Ljoney","avatar":"https://static.tigerbbs.com/8376cac12c1b661feac4d507eb1379e4","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":864423171,"type":1,"supId":6066544,"prevId":0,"content":"Nice","text":"Nice","html":"Nice"}],"langContent":"CN"},{"id":864488509,"gmtCreate":1633138758038,"gmtModify":1633138758234,"author":{"id":"3581825520109338","authorId":"3581825520109338","name":"Imgoh","avatar":"https://static.tigerbbs.com/37ecbebf2e324891c637f8afc0232f89","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"No wonder vaccine stock drop so much","listText":"No wonder vaccine stock drop so much","text":"No wonder vaccine stock drop so much","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864488509","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6066572,"gmtCreate":1633140345262,"gmtModify":1634724248593,"authorId":3581896632900578,"author":{"id":3581896632900578,"authorId":3581896632900578,"name":"Baoxiaolong","avatar":"https://static.tigerbbs.com/3807f63227b4128c0ee5f1811f39e3eb","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":864488509,"type":1,"supId":0,"prevId":0,"content":"you think this is over?","text":"you think this is over?","html":"you think this is over?"}],"langContent":"CN"},{"id":864411924,"gmtCreate":1633138000297,"gmtModify":1633138000980,"author":{"id":"3581978054709801","authorId":"3581978054709801","name":"Nickystonks","avatar":"https://static.tigerbbs.com/9ea10f153b0e264f05c7d19fcc08cdee","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Very interesting progress","listText":"Very interesting progress","text":"Very interesting progress","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864411924","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":864557464,"gmtCreate":1633134358109,"gmtModify":1633134360319,"author":{"id":"3574326723774097","authorId":"3574326723774097","name":"Gackky","avatar":"https://static.tigerbbs.com/5898b44bf5a31bf2b9d4e37227ed8177","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"after vaccination , we will need to eat pill?! next will be nanabots perhaps&nbsp;","listText":"after vaccination , we will need to eat pill?! next will be nanabots perhaps&nbsp;","text":"after vaccination , we will need to eat pill?! next will be nanabots perhaps","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864557464","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":864552315,"gmtCreate":1633134237431,"gmtModify":1633134237655,"author":{"id":"3586059298879232","authorId":"3586059298879232","name":"Tomxx","avatar":"https://static.tigerbbs.com/abd49c57222b3b842f3f9af84b9d5b97","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864552315","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6065538,"gmtCreate":1633136505030,"gmtModify":1634724346085,"authorId":3571822130411286,"author":{"id":3571822130411286,"authorId":3571822130411286,"name":"Jweikit","avatar":"https://static.tigerbbs.com/b483f2ee96e5c438b841f3c0a8e4ccdf","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":864552315,"type":1,"supId":0,"prevId":0,"content":"Nice","text":"Nice","html":"Nice"}],"langContent":"CN"},{"id":864524651,"gmtCreate":1633133706760,"gmtModify":1633133707488,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Waiting for a liquid oral vaccine or a plaster type of&nbsp; vaccine.&nbsp;","listText":"Waiting for a liquid oral vaccine or a plaster type of&nbsp; vaccine.&nbsp;","text":"Waiting for a liquid oral vaccine or a plaster type of vaccine.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864524651","repostId":1118501905,"repostType":2,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6065172,"gmtCreate":1633135288935,"gmtModify":1634724379095,"authorId":3569750028742479,"author":{"id":3569750028742479,"authorId":3569750028742479,"name":"cheekeong","avatar":"https://static.tigerbbs.com/064e35722748144f5c935ee80c48733c","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":864524651,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"CN"},{"id":864528464,"gmtCreate":1633133435868,"gmtModify":1633133436684,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Truly a game changer.[强]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[梭哈]&nbsp;[美金]&nbsp;[美金]&nbsp;[看涨]&nbsp;[财迷]&nbsp;","listText":"Truly a game changer.[强]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[梭哈]&nbsp;[美金]&nbsp;[美金]&nbsp;[看涨]&nbsp;[财迷]&nbsp;","text":"Truly a game changer.[强] [看涨] [看涨] [梭哈] [美金] [美金] [看涨] [财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864528464","repostId":1118501905,"repostType":2,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":864568530,"gmtCreate":1633132872168,"gmtModify":1633132872168,"author":{"id":"3574381076586256","authorId":"3574381076586256","name":"KYHBKO","avatar":"https://static.tigerbbs.com/c3bcbc7f9a10836dea92afc94bf39b5b","vip":2,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"this is a game changer without the restrictions of cold chain storage and transportation required, thus allowing this to reach more people especially in more remote areas. at the same time, some people would prefer to consume the pill than receiving injection. no surprise that the stock did well.&nbsp;","listText":"this is a game changer without the restrictions of cold chain storage and transportation required, thus allowing this to reach more people especially in more remote areas. at the same time, some people would prefer to consume the pill than receiving injection. no surprise that the stock did well.&nbsp;","text":"this is a game changer without the restrictions of cold chain storage and transportation required, thus allowing this to reach more people especially in more remote areas. at the same time, some people would prefer to consume the pill than receiving injection. no surprise that the stock did well.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/864568530","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6064667,"gmtCreate":1633133139988,"gmtModify":1634724424767,"authorId":4087534721377030,"author":{"id":4087534721377030,"authorId":4087534721377030,"name":"714ec067","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":864568530,"type":1,"supId":0,"prevId":0,"content":"👍","text":"👍","html":"👍"},{"id":6068584,"gmtCreate":1633154033033,"gmtModify":1634724064055,"authorId":4091089381144950,"author":{"id":4091089381144950,"authorId":4091089381144950,"name":"滚股怪","avatar":"https://static.tigerbbs.com/b67621b4133ca0db91bff9766152a448","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":864568530,"type":1,"supId":0,"prevId":0,"content":"Ya","text":"Ya","html":"Ya"},{"id":6068929,"gmtCreate":1633156704836,"gmtModify":1634724031215,"authorId":3567916089112278,"author":{"id":3567916089112278,"authorId":3567916089112278,"name":"KLC","avatar":"https://static.tigerbbs.com/7b5f29591734279d9235e132e16aa719","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":864568530,"type":1,"supId":6064667,"prevId":0,"content":"👍","text":"👍","html":"👍"},{"id":6064663,"gmtCreate":1633133111672,"gmtModify":1633133111672,"authorId":3560652149389543,"author":{"id":3560652149389543,"authorId":3560652149389543,"name":"plaispool","avatar":"https://static.tigerbbs.com/4e73f25703acab79329cb615cff70000","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":864568530,"type":1,"supId":0,"prevId":0,"content":"👀","text":"👀","html":"👀"}],"langContent":"CN"},{"id":864584222,"gmtCreate":1633132341987,"gmtModify":1633132342415,"author":{"id":"4088599389256890","authorId":"4088599389256890","name":"Andersonkana","avatar":"https://static.tigerbbs.com/21e08c99709245ba5acdcf7245d9c40f","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Good news","listText":"Good news","text":"Good news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864584222","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":864582225,"gmtCreate":1633132195083,"gmtModify":1633132195436,"author":{"id":"3563665738915585","authorId":"3563665738915585","name":"Tongdadd","avatar":"https://static.tigerbbs.com/79e519b2023d6e7e3b68e295f81f3e8e","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"Hope they don't price this drug out of the reach of many poor countries&nbsp;","listText":"Hope they don't price this drug out of the reach of many poor countries&nbsp;","text":"Hope they don't price this drug out of the reach of many poor countries","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/864582225","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6067650,"gmtCreate":1633146364086,"gmtModify":1634724146757,"authorId":4088082610944870,"author":{"id":4088082610944870,"authorId":4088082610944870,"name":"SmallYang","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":864582225,"type":1,"supId":0,"prevId":0,"content":"Agree. As it is, the vaccines are now almost out of reach to the poorer countries. :(","text":"Agree. As it is, the vaccines are now almost out of reach to the poorer countries. :(","html":"Agree. As it is, the vaccines are now almost out of reach to the poorer countries. :("},{"id":6088432,"gmtCreate":1633345225483,"gmtModify":1634722306192,"authorId":3563665738915585,"author":{"id":3563665738915585,"authorId":3563665738915585,"name":"Tongdadd","avatar":"https://static.tigerbbs.com/79e519b2023d6e7e3b68e295f81f3e8e","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":864582225,"type":1,"supId":0,"prevId":0,"content":"Crazy. US$700 per pill. One course is 5 days. Minimally US$3500 to pay for a course of medication. Profiteering by Big Pharma at its max. What happened to saving lives?","text":"Crazy. US$700 per pill. One course is 5 days. Minimally US$3500 to pay for a course of medication. Profiteering by Big Pharma at its max. What happened to saving lives?","html":"Crazy. US$700 per pill. One course is 5 days. Minimally US$3500 to pay for a course of medication. Profiteering by Big Pharma at its max. What happened to saving lives?"}],"langContent":"CN"},{"id":864583165,"gmtCreate":1633131740768,"gmtModify":1633131756539,"author":{"id":"3586941861951066","authorId":"3586941861951066","name":"EHG","avatar":"https://static.tigerbbs.com/28e4734e50f795c3218330cbb6c3e9a0","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864583165","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":864580325,"gmtCreate":1633131564977,"gmtModify":1633131565207,"author":{"id":"4090061020789410","authorId":"4090061020789410","name":"UserTesting2","avatar":"https://static.tigerbbs.com/7313d9a1299ffe8126deb142bded1ca3","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864580325","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":864517530,"gmtCreate":1633131517183,"gmtModify":1633131517290,"author":{"id":"4092362709546440","authorId":"4092362709546440","name":"Benggggg","avatar":"https://static.tigerbbs.com/387527a4f7ae535360879cc7a7cf7e15","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"👍Ok&nbsp;","listText":"👍Ok&nbsp;","text":"👍Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864517530","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":864517118,"gmtCreate":1633131472730,"gmtModify":1633131473872,"author":{"id":"3576274545052910","authorId":"3576274545052910","name":"Kevin92","avatar":"https://static.tigerbbs.com/c5ff4addbbdb8d9d15fec29f9709b0c3","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"like and commet","listText":"like and commet","text":"like and commet","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864517118","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":864515552,"gmtCreate":1633131361987,"gmtModify":1633131388959,"author":{"id":"3581919031797456","authorId":"3581919031797456","name":"JeffreyNeo","avatar":"https://static.tigerbbs.com/fd016aa2ec66a904f877445461310e24","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":3,"crmLevelSwitch":0},"htmlText":"1","listText":"1","text":"1","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/864515552","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6064323,"gmtCreate":1633131367491,"gmtModify":1634724453046,"authorId":3581919031797456,"author":{"id":3581919031797456,"authorId":3581919031797456,"name":"JeffreyNeo","avatar":"https://static.tigerbbs.com/fd016aa2ec66a904f877445461310e24","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":864515552,"type":1,"supId":0,"prevId":0,"content":"1","text":"1","html":"1"},{"id":6064348,"gmtCreate":1633131468340,"gmtModify":1634724451092,"authorId":3576274545052910,"author":{"id":3576274545052910,"authorId":3576274545052910,"name":"Kevin92","avatar":"https://static.tigerbbs.com/c5ff4addbbdb8d9d15fec29f9709b0c3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":864515552,"type":1,"supId":0,"prevId":0,"content":"‌like and commet","text":"‌like and commet","html":"‌like and commet"}],"langContent":"CN"},{"id":864515977,"gmtCreate":1633131324347,"gmtModify":1633131386673,"author":{"id":"3580072870029753","authorId":"3580072870029753","name":"YauDK","avatar":"https://static.tigerbbs.com/4e00c10df4000c04392220903422d15f","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Oh ye ye&nbsp;","listText":"Oh ye ye&nbsp;","text":"Oh ye ye","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864515977","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6064312,"gmtCreate":1633131333436,"gmtModify":1634724453911,"authorId":3580072870029753,"author":{"id":3580072870029753,"authorId":3580072870029753,"name":"YauDK","avatar":"https://static.tigerbbs.com/4e00c10df4000c04392220903422d15f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":864515977,"type":1,"supId":0,"prevId":0,"content":"Oh ye ye ","text":"Oh ye ye ","html":"Oh ye ye "}],"langContent":"CN"},{"id":864512599,"gmtCreate":1633131297827,"gmtModify":1633131298077,"author":{"id":"3581539047362830","authorId":"3581539047362830","name":"Sunny0809","avatar":"https://static.tigerbbs.com/3ffb7aab0292fd1f17dfb9f99bc5eb03","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864512599","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":864599440,"gmtCreate":1633128986314,"gmtModify":1633128987271,"author":{"id":"3578983795474363","authorId":"3578983795474363","name":"DesmondChin","avatar":"https://static.tigerbbs.com/b90cb6b6a6c328ac8d02a829e5e7c835","vip":1,"hat":"https://static.tigerbbs.com/46b6808e1ba3716fb9c53339adffa3c5","crmLevel":3,"crmLevelSwitch":0},"htmlText":"Nothing new, just another panaodol that protects against covid.. After 10years, no one would even remember what happen to this so called game changing events","listText":"Nothing new, just another panaodol that protects against covid.. After 10years, no one would even remember what happen to this so called game changing events","text":"Nothing new, just another panaodol that protects against covid.. After 10years, no one would even remember what happen to this so called game changing events","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864599440","repostId":1118501905,"repostType":4,"repost":{"id":"1118501905","pubTimestamp":1633097579,"share":"https://www.laohu8.com/m/news/1118501905?lang=&edition=full","pubTime":"2021-10-01 22:12","market":"us","language":"en","title":"Merck's COVID pill a 'game-changer' - Scott Gottlieb","url":"https://stock-news.laohu8.com/highlight/detail?id=1118501905","media":"seekingalpha","summary":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott G","content":"<p></p>\n<ul>\n <li>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.</li>\n <li>Gottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).</li>\n <li>The Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.</li>\n <li>Gottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"</li>\n <li>Merck (MRK) ishigher by 7.6%&nbsp;premarket.</li>\n <li>Vaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's COVID pill a 'game-changer' - Scott Gottlieb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's COVID pill a 'game-changer' - Scott Gottlieb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ...</p>\n\n<a href=\"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3746900-mercks-covid-pill-a-game-changer-scott-gottlieb","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1118501905","content_text":"Merck's(NYSE:MRK)COVID treatment pill resultsare \"profoundly\" positive, says former FDA boss Scott Gottlieb, appearing on CNBCfollowing the release of the test results.\nGottlieb notes the trial was ended early as the great success the drug was showing meant it would be unethical to continue giving folks placebos. More than 700 unvaccinated symptomatic people were given the drug, with 7% of this group needing hospitalization (and none dying) vs. 14% of the placebo group needing hospitalization (and 8 dying).\nThe Pfizer board member further notes the safely profile will probably be excellent as patients only need take the drug for about 5 days - think the popular tamiflu treatment that many take for the flu.\nGottlieb: \"This is a phenomenal result. This is a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic.\"\nMerck (MRK) ishigher by 7.6% premarket.\nVaccine makers are lower across the board: Pfizer(NYSE:PFE), Moderna(NASDAQ:MRNA), BioNTech(NASDAQ:BNTX), Novavax(NASDAQ:NVAX).","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":448,"commentSize":84,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}